Filament Health FLHLF FH is a clinical-stage psychedelic drug development company creating safe, standardized, naturally-derived psychedelic medicines.
CEO and Co-Founder Benjamin Lightburn spoke at the Benzinga Psychedelics Capital Conference, April 19, 2022, about the psychedelics industry, the clinical development of psychedelic medicines and how Filament is paving the way with today’s first-ever natural psychedelic drug candidates.
Watch the full video here.
Image via Filament Health
This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
